晚期冠心病治疗的新进展(3)
参考文献
1. Mirhoseini M; Revascularization of the myocardium with laser , In Davila JC (ed): Second Herry ford Hospital International Symposium on cardiac Surgery . New York , Appleten-Century-Crefts, 1977. Pp 595-597.
2. Mirhoseini M, Shelgikar S, Cayton MM, New Concepts in revascularization of the myocardium. Ann Thorac Surg, 1988,45:415.
3. Keith A,Lawrence H,Denton A,et al.Transmyocardial Laser Revascularization:Results of a multer-center trial using TMLR as sole therapy for end-stage coronary artery disease.American Association for Thoracic Surgeons .April,1998.
, 百拇医药
4. Keith A Horvath, Lawrence H Cohn,Denton A Cooley,et al. Functional Improvement,Long term survival and angina relief after transmyocardial revascularization with a CO2 laser.American heart association 1998 Dallas,Texas November,1998.
5. Robert D Dowling,Keith B Allen,Tommy Fudge,et al.Recent experience of transmyocardial revascularization in a prospective randomized trial demonstrates dramatic symptom relief and excellent safety profile.American College of cardiology scientific session March,1999.
, 百拇医药
6. Keith B Allen,Anthony J Delrossi,Edward A Lefrak,et al.Transmyocardial revascularization Combined with coronary artery bypass grafting versus bypass grafting alone:A prospective,randomized multer-center trial.American association of Thoracic surgery 1999 new orieans,LA April,1999.
7.Cooley Da , Frazier OH, Kadipasaoglu KA, et al: Transmyocardial laser revascularization, Anatomic evidence of long-term channel patency, Tex Heart Inst J 1994;21:220-4
, 百拇医药
8.Krabatsch T, schaper F, Leder C, et al : Histological findings after transmyocardial laser revascularization. J Card Surg 1996;11:326-31.
9. Stock U, Meliss R, Harringer W, et al : cardiac hixtopathology 9 months after laser revascularization (TMR). Thora Cardiovasc Surg 1997,45(suppl 1) :147.
10. Gassler N, Winzer HO, Stubbe HM, et al :transmyocardial laser revascularization: Histological features in human nonresponder myocardium. Circulation 1997;95:371-351.
, 百拇医药
11. Kwong KF, Kanellopoulos GK, Nickols JC, et al: Transmyocardial laser treatment denevates canine myocardium, J Thorac Cardiovasc Surg 1997;6:883-889.
12. Mack CA, Patel SR, Schwarz EA , et al , Biologic bypass with the use of adenovirua-mediateded gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and funtion in the ischemic porcine heart , J Thorac Cardiovasc Surg, 1998 115 (1):168-176.
, http://www.100md.com
13. Montin E, Regulation of myosin heavy chain genes in the heart, Circulation, 1993,87:1451-1460.
14. Banai S, Jaklitsch MT, Shou M, et al ,Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in doga. Circulation 1994,89(5):2183-2189.
15. anagisawa MA, Vchida Y, Nakamura F, et al . Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor, Science . 1992,257 (5705):1401-1430.
, http://www.100md.com
16. Douglas W Losordo,Peter R Vale,James F Symes,et al.Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.Circulation.1998;98:2800-2804.
17. Aiello Lp, Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders . N.Eng .J.Med. 1994,331:1480-1487.
18. Lazarous DF, Shou M,Scheinowitz M, et al , Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury . Circulation , 1996,94(5):1074-1082.
19. Mazue G, Bertolero F ,Jacob C, et al . preclinical and clinical studies with recombinant basic fibroblast growth factor, Ann N.Y.Acad. Sci. 1991,638:329-340., 百拇医药(王日胜 霍勇)
1. Mirhoseini M; Revascularization of the myocardium with laser , In Davila JC (ed): Second Herry ford Hospital International Symposium on cardiac Surgery . New York , Appleten-Century-Crefts, 1977. Pp 595-597.
2. Mirhoseini M, Shelgikar S, Cayton MM, New Concepts in revascularization of the myocardium. Ann Thorac Surg, 1988,45:415.
3. Keith A,Lawrence H,Denton A,et al.Transmyocardial Laser Revascularization:Results of a multer-center trial using TMLR as sole therapy for end-stage coronary artery disease.American Association for Thoracic Surgeons .April,1998.
, 百拇医药
4. Keith A Horvath, Lawrence H Cohn,Denton A Cooley,et al. Functional Improvement,Long term survival and angina relief after transmyocardial revascularization with a CO2 laser.American heart association 1998 Dallas,Texas November,1998.
5. Robert D Dowling,Keith B Allen,Tommy Fudge,et al.Recent experience of transmyocardial revascularization in a prospective randomized trial demonstrates dramatic symptom relief and excellent safety profile.American College of cardiology scientific session March,1999.
, 百拇医药
6. Keith B Allen,Anthony J Delrossi,Edward A Lefrak,et al.Transmyocardial revascularization Combined with coronary artery bypass grafting versus bypass grafting alone:A prospective,randomized multer-center trial.American association of Thoracic surgery 1999 new orieans,LA April,1999.
7.Cooley Da , Frazier OH, Kadipasaoglu KA, et al: Transmyocardial laser revascularization, Anatomic evidence of long-term channel patency, Tex Heart Inst J 1994;21:220-4
, 百拇医药
8.Krabatsch T, schaper F, Leder C, et al : Histological findings after transmyocardial laser revascularization. J Card Surg 1996;11:326-31.
9. Stock U, Meliss R, Harringer W, et al : cardiac hixtopathology 9 months after laser revascularization (TMR). Thora Cardiovasc Surg 1997,45(suppl 1) :147.
10. Gassler N, Winzer HO, Stubbe HM, et al :transmyocardial laser revascularization: Histological features in human nonresponder myocardium. Circulation 1997;95:371-351.
, 百拇医药
11. Kwong KF, Kanellopoulos GK, Nickols JC, et al: Transmyocardial laser treatment denevates canine myocardium, J Thorac Cardiovasc Surg 1997;6:883-889.
12. Mack CA, Patel SR, Schwarz EA , et al , Biologic bypass with the use of adenovirua-mediateded gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and funtion in the ischemic porcine heart , J Thorac Cardiovasc Surg, 1998 115 (1):168-176.
, http://www.100md.com
13. Montin E, Regulation of myosin heavy chain genes in the heart, Circulation, 1993,87:1451-1460.
14. Banai S, Jaklitsch MT, Shou M, et al ,Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in doga. Circulation 1994,89(5):2183-2189.
15. anagisawa MA, Vchida Y, Nakamura F, et al . Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor, Science . 1992,257 (5705):1401-1430.
, http://www.100md.com
16. Douglas W Losordo,Peter R Vale,James F Symes,et al.Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.Circulation.1998;98:2800-2804.
17. Aiello Lp, Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders . N.Eng .J.Med. 1994,331:1480-1487.
18. Lazarous DF, Shou M,Scheinowitz M, et al , Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury . Circulation , 1996,94(5):1074-1082.
19. Mazue G, Bertolero F ,Jacob C, et al . preclinical and clinical studies with recombinant basic fibroblast growth factor, Ann N.Y.Acad. Sci. 1991,638:329-340., 百拇医药(王日胜 霍勇)